Pyridine → HCID 20393037, compound
Reaction equation
[C:1]([Cl:4])(Cl)=[O:2].[CH3:5][C:6]1[CH:7]=[C:8]([CH3:23])[C:9]2[C:15](=[O:16])[N:14]([CH3:17])[C:13]3[CH:18]=[CH:19][CH:20]=[CH:21][C:12]=3[NH:11][C:10]=2[N:22]=1.C(C(CC)=O)C.N1C=CC=CC=1>C1(C)C=CC=CC=1.O>[Cl:4][C:1]([N:11]1[C:12]2[CH:21]=[CH:20][CH:19]=[CH:18][C:13]=2[N:14]([CH3:17])[C:15](=[O:16])[C:9]2[C:8]([CH3:23])=[CH:7][C:6]([CH3:5])=[N:22][C:10]1=2)=[O:2]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 110 °C
Procedure
50 ml of a 20% solution of phosgene in toluene were added dropwise over a period of 10 minutes to a mixture consisting of 10.0 gm of 6,11-dihydro-2,4,6-trimethyl-5H-pyrido[2,3-b][1,5]-benzodiazepin-5-one, 100 ml of diethyl ketone, 50 ml of toluene and 5 ml of pyridine. The resulting mixture was heated at 60° C. for 2 hours, at 80° C. for one hour and at 110° C. for one hour, while stirring. After cooling to room temperature, 100 ml of water were added. The organic phase was dried with sodium sulfate and then evaporated in vacuo. The residue was recrystallized twice from ethanol, yielding 7.3 gm of 11-chloroformyl-6,11-dihydro-2,4,6-trimethyl-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one, m.p. 205°-207° C.
Workup
- temperatureAfter cooling to room temperature
- dry with materialThe organic phase was dried with sodium sulfate
- customevaporated in vacuo
- customThe residue was recrystallized twice from ethanol
Sources & evidence
- ORD record
- ord-00f7ed3dd2724bccbdf5fd750d869694
- Source dataset
- uspto-grants-1979_09
- Patent number
- US04167570
Reaction notes
Loading…